Tejas Savant

Stock Analyst at Morgan Stanley

(0)
# 4428
Out of 5,378 analysts
298
Total ratings
Success rate
Average return
39 Stocks
Name Action PT Current % Upside Ratings Updated
CTKB Cytek Biosciences
Maintains: Equal-Weight
9 7
3.12 124.36% 9 May 28, 2025
TXG 10x Genomics
Maintains: Overweight
26 18
10.8 66.67% 14 May 19, 2025
ILMN Illumina
Maintains: Equal-Weight
136 100
90.66 10.3% 8 May 12, 2025
TEM Tempus AI
Maintains: Overweight
60 65
65.67 -1.02% 3 May 9, 2025
HOLX Hologic
Maintains: Equal-Weight
77 65
64.43 0.88% 9 May 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
8 7
6.57 6.54% 2 May 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
7 9
10.52 -14.45% 12 May 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
17 10
6.97 43.47% 13 May 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
25 15
13.45 11.52% 17 Apr 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
7 5
2.12 135.85% 13 Mar 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
16 20
43.04 -53.53% 2 Mar 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
176 185
170.47 8.52% 13 Mar 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
245 250
155.41 60.86% 11 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
647 678
400.32 69.36% 14 Jan 31, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Equal-Weight
24 23
23.63 -2.67% 1 Dec 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
26 28
26.66 5.03% 12 Nov 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
32 21
4.87 331.21% 2 Nov 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
4 2
1.19 68.07% 11 Aug 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
4 3
1.28 134.38% 10 Aug 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
80 40
8.54 368.38% 2 May 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
26 26
n/a n/a 12 Mar 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
14 8
n/a n/a 11 Oct 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
52 55
n/a n/a 11 Aug 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Equal-Weight
1
n/a n/a 1 Aug 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Equal-Weight
6 6
0.7 757.14% 3 Aug 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
11 10
3.05 227.87% 8 May 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Equal-Weight
3
3.17 -13.25% 6 Mar 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
11 5
6.2 -19.35% 12 Feb 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
11 10
1.98 405.05% 10 Feb 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
80 73
48.52 50.45% 9 Feb 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
5 2
n/a n/a 5 Jan 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
10 8
n/a n/a 4 Aug 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
10 5
n/a n/a 8 Aug 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
350 250
147.42 69.58% 1 Aug 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
7 5
n/a n/a 5 May 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
17 19
n/a n/a 3 May 6, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
18 17
n/a n/a 8 May 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
21 20
n/a n/a 2 Mar 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
35 65
n/a n/a 1 Feb 22, 2021